Winn-Deen ES
Oncor, Inc, Gaithersburg, Maryland
Mol Diagn. 1998 Dec;3(4):217-221. doi: 10.154/MODI00300217.
Background: Currently analysis of point mutations can be done by allele-specific polymerase chain reaction (PCR) followed by gel analysis or by gene-specific PCR followed by hybridization with an allele-specific probe. Both of these mutation detection methods require post-PCR laboratory time and run the risk of contaminating subsequent experiments with the PCR product liberated during the detection step. The author has combined the PCR amplification and detection steps into a single procedure suitable for closed-tube analysis. Methods and Results: Allele-specific PCR primers were designed as Sunrise energy-transfer primers and contained a 3' terminal mismatch to distinguish between normal and mutant DNA. Cloned normal (W64) and mutant (R64) templates of the beta3-adrenergic receptor gene were tested to verify amplification specificity and yield. A no-target negative control was also run with each reaction. After PCR, each reaction was tested for fluorescence yield by measuring fluorescence on a spectrofluorimeter or fluorescent microtitreplate reader. The cloned controls and 24 patient samples were tested for the W64R mutation by two methods. The direct fluorescence results with the Sunrise allele-specific PCR method gave comparable genotypes to those obtained with the PCR/ restriction digest/gel electrophoresis control method. No PCR artifacts were observed in the negative controls or in the PCR reactions run with the mismatched target. Conclusions: The results of this pilot study indicate good PCR product and fluorescence yield from allele-specific energy-transfer labeled primers, and the capability of distinguishing between normal and mutant alleles based on fluorescence alone, without the need for restriction digestion, gel electrophoresis, or hybridization with an allele-specific probe.
目前,点突变分析可通过等位基因特异性聚合酶链反应(PCR),随后进行凝胶分析,或通过基因特异性PCR,随后与等位基因特异性探针杂交来完成。这两种突变检测方法都需要PCR后的实验室操作时间,并且存在在检测步骤中释放的PCR产物污染后续实验的风险。作者已将PCR扩增和检测步骤合并为一个适用于闭管分析的单一程序。
等位基因特异性PCR引物被设计为Sunrise能量转移引物,并在3'末端含有错配以区分正常和突变DNA。对β3 - 肾上腺素能受体基因的克隆正常(W64)和突变(R64)模板进行测试,以验证扩增特异性和产量。每个反应还进行无靶标阴性对照。PCR后,通过在荧光分光光度计或荧光酶标仪上测量荧光来测试每个反应的荧光产量。通过两种方法对克隆对照和24个患者样本进行W64R突变检测。Sunrise等位基因特异性PCR方法的直接荧光结果与PCR/限制性消化/凝胶电泳对照方法获得的基因型相当。在阴性对照或与错配靶标进行的PCR反应中未观察到PCR假象。
这项初步研究的结果表明,等位基因特异性能量转移标记引物具有良好的PCR产物和荧光产量,并且仅基于荧光就能区分正常和突变等位基因,无需限制性消化、凝胶电泳或与等位基因特异性探针杂交。